ホーム
マーケット
チャート&アイデア
Algo
ニュース
Store
ブローカー
ダウンロード
経済指標カレンダー
取引シグナル
Webターミナル
「
/
」を入力して検索:@user、$symbol
検索
ログイン
アカウントを作成
日本語
English
Русский
中文
Español
Português
Deutsch
한국어
Français
Italiano
Türkçe
ACAD
#1236
Acadia Pharmaceuticals Inc.
24.5
6
+1.24%
セクター:
ベース:
利益通貨:
日中レンジ
1年のレンジ
1日の変化
+1.24%
月次変化
-6.83%
6か月変化
-7.08%
1年の変化
+28.05%
以前の終値
24.2
6
Open
24.5
6
Bid
Ask
Low
24.5
6
High
24.5
6
ボリューム
140
マーケット
株
ヘルスケア
ACAD
Open full chart
Financials
Overview
明細書
Statistics
Dividends
Quarterly
Annual
Value
Q3, 24
Q4, 24
Q1, 25
Q2, 25
Q3, 25
Q4, 25
TTM
Key stats
Total common shares outstanding
166.39 M
166.79 M
167.36 M
168.71 M
169.18 M
170.49 M
—
Valuation ratios
Enterprise value
2.4 B
2.74 B
2.56 B
3.39 B
3.35 B
4.38 B
13.68 B
Price to earnings ratio
19.72
13.49
12.12
16.22
13.77
11.61
53.72
Price to sales ratio
0.01
3.19
2.78
3.54
3.42
—
—
Price to cash flow ratio
0.03
19.36
18.56
19.18
18.03
41.32
97.09
Price to book ratio
0.01
4.17
1.07
1.24
1.11
3.7
7.12
Enterprise value to EBITDA ratio
22.9
7.43
32.18
41.31
38.22
—
—
Profitability ratios
Return on assets %
0.03
0.12
0.02
0.02
0.05
0.17
0.27
Return on equity %
0.06
0.2
0.02
0.03
0.08
0.22
0.36
Return on invested capital %
57.08
250.17
20.65
32.63
76.69
-123.27
6.7
Gross margin %
92.47
91.6
91.65
92.16
92.23
90.77
366.81
Operating margin %
12.64
59.13
7.9
12.24
12.83
6.12
39.09
EBITDA margin %
11.63
1.69
7.12
11.74
12.52
5.96
37.34
Net margin %
13.09
55.37
7.77
10.08
25.76
96.33
139.94
Liquidity ratios
Quick ratio
2.04
2.14
2.54
2.58
2.72
3.43
11.27
Current ratio
2.29
2.38
2.88
2.91
3.02
3.83
12.64
Inventory turnover
0.22
0.24
0.21
0.19
0.2
0.24
0.85
Asset turnover
0.26
0.24
0.21
0.22
0.22
0.2
0.85
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
0.38
0.24
0.12
0.38
0.44
-0.29
0.65
EBIT per share
0.13
-0.05
0.1
0.16
0.16
0.04
0.46
EBITDA per share
0.18
0.03
0.1
0.18
0.2
0.1
0.59
Total debt per share
—
—
—
—
—
—
—
Cash per share
3.4
4.54
4.07
4.52
4.96
4.82
18.37
Net current asset value per share
4.74
5.64
5.19
5.69
6.31
6.25
23.45
Tangible book value per share
2.84
3.68
3.87
4.2
4.72
6.58
19.37
Working capital per share
2.67
3.27
3.39
3.74
4.22
4.62
15.97
Book value per share
3.47
4.4
4.56
4.88
5.38
7.22
22.04
ACADIA Pharmaceuticals Inc
Acadia Pharmaceuticals Inc. is a biopharmaceutical company headquartered in Del Mar, San Diego, California.
ニュース
Acadia Pharmaceuticals: Undervalued Despite Robust Revenues From Approved Drugs (ACAD)
ACAD Q4 Earnings Beat, Nuplazid & Daybue Drive Y/Y Revenue Growth
Jefferies、ガイダンスを受けてAcadia Pharmaceuticals株の目標株価を引き上げ
Jefferies raises Acadia Pharmaceuticals stock price target on guidance
Citizens、成長見通しを理由にAcadia Pharmaceuticals目標株価を引き上げ
Citizens raises Acadia Pharmaceuticals price target on growth outlook
ACADIA Pharmaceuticals Inc. (ACAD) Q4 2025 Earnings Call Transcript
ACADIA Pharmaceuticals Inc. 2025 Q4 - Results - Earnings Call Presentation (NASDAQ:ACAD) 2026-02-25
Acadia Pharmaceuticals (ACAD) Q4 Earnings Top Estimates
ACADIA Q4 2025 slides: $1B revenue milestone as both drugs post double-digit growth
Acadia決算発表控える:利益圧迫にもかかわらず収益成長を予想
Wolfe ResearchがAcadia株をアウトパフォーム評価でカバレッジ開始